Biotech

All Articles

AvenCell bags $112M to flip 'switchable' CAR-Ts in the medical clinic

.AvenCell Therapies has gotten $112 thousand in series B funds as the Novo Holdings-backed biotech f...

China- located biotech plannings ph. 3 after seeing midstage eye records

.China-based Minghui Pharmaceutical has connected its thyroid eye illness procedure to a reduction i...

Sangamo slashes time to market for Fabry gene therapy as FDA consents to increased authorization plan

.Sangamo Rehabs has identified a quick way to market for its Fabry ailment prospect, aligning with t...

Otsuka's kidney illness medicine strengthens UPCR levels in ph. 3 test

.Otsuka Pharmaceutical's kidney disease medication has reached the major endpoint of a period 3 test...

Roche discards $120M tau prospect, sending back civil rights to UCB

.Roche has returned the civil rights to UCB's anti-tau antibody bepranemab, walking away from a $120...

Editas reinforces in vivo approach through $238M Genenvant treaty

.Editas Medicines has actually authorized a $238 million biobucks contract to incorporate Genevant S...

Combo end results, Vicodin overlook and also stellar security

.Tip has actually mentioned phase 3 records on its near-approval ache medication applicant suzetrigi...

Angelini markers $360M biobucks deal for ph. 1 mind disorder drug

.Italy's Angelini Pharma has authorized a $360 million biobucks pact centered on a phase 1-stage hum...

Sage gives up half of R&ampD team as well as shakes up C-suite again

.Sage Rehabs' newest attempt to shrink its own pipe as well as staff will certainly find a 3rd of th...

With period 1 information, Aura has an eye on early-stage bladder cancer cells

.Along with its lead candidate in a stage 3 test for an unusual eye cancer cells, Feeling Bioscience...